Natura Tesamorelin
A pre-filled GHRH analog pen for growth hormone research protocols — dial precise increments without reconstituting vials or loading syringes.
- 44–amino-acid GHRH analog with trans-3-hexenoic acid modification
- Studied for pituitary GH release and visceral adipose reduction
- Independent COA on every released batch
Certificate of analysis, tied to your pen.
Enter the batch code printed on your box or pen body. Every Natura SKU ships with independent lab paperwork before it leaves our facility.
COA lookups are also handled by email — include your batch code and we reply within one business day.
| Batch | Manufactured | Purity | Status | COA |
|---|---|---|---|---|
| TES-2026-001 | Jan 2026 | ≥98.8% | Released | Download PDF |
| TES-2025-007 | Nov 2025 | ≥98.6% | Released | Download PDF |
Pen details
- Format
- Pre-filled dial pen
- Fill volume
- 3 mL
- Increment
- 0.5 mg per click
- Storage
- Refrigerate (2–8 °C). Protect from light.
Peptide profile
- Compound
- Tesamorelin (GHRH analog)
- Sequence / form
- 44-mer GHRH(1-44) analog — acetate salt, hexenoyl-modified
- Typical use
- Growth hormone & body composition research
- Testing
- HPLC purity, mass spec identity, endotoxin screen
Pituitary GHRH signaling, not exogenous growth hormone.
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) with a trans-3-hexenoic acid modification that extends half-life — studied for its ability to stimulate endogenous GH release from the pituitary and reduce visceral adipose tissue in clinical research.
It is not FDA-approved for medical use. Natura ships it as a batch-verified research pen so you can dial a consistent dose and read the lab paperwork before you open the box.
Full benefits & side effects guide